Alternative Data for Healthcare Investors (Part IV): Claims vs EHRs
In the following Intelligence piece, we explore healthcare claims and electronic health records (EHRs) as alternative data sources for investors. Healthcare claims and EHRs can offer valuable insights into drug/medical device prescribing and utilisation trends. This information has clear applications for investors in pharmaceutical, biotech, and medical device/equipment companies as well as companies responsible for paying healthcare claims such as managed care organisations or other health insurers.
As discussed in Part I of this Neudata Intelligence series, healthcare claims and electronic health records (EHRs) are two sources of Real-World Data (RWD) (i.e. they are generated outside of controlled clinical research settings) that can be utilised by investors.
Use cases primarily revolve around the utilisation of a pharmaceutical/biotech/medical device company’s marketed products, which can be used as a proxy for product sales.